This premier B2B event provides the appropriate platform to engage and discuss ideas with your peers, while facilitating a professional atmosphere and environment for good company representation and development.
The summit will shed light on current challenges, best practices and the inside view of the future of ADCs.
We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in the ADCs landscape.
Key Practical Learning Points of the Summit:
Who Should Attend:
Chief Executives, Vice Presidents, Directors, Department Heads, Leaders, Managers, Clinical Development Experts and Scientists specialising in:
Dr. Rakesh Dixit Vice President, Research & Development / Global Head, Biologics Safety Assessment Medimmune a member of Astrazeneca Group
Dr. Björn Hock Senior Director, Global Head ADCs & Targeted NBE Therapeutics Merck KGaA, Germany
Dr. Ling Xu Bioanalysis of Small Molecules & Antibody Drug Conjugates Mersana Therapeutics, Inc. (represented Millennium Pharmaceuticals, Inc., subsidiary of Takeda), US
Dr. Olivier Heudi Laboratory Head Novartis AG, Switzerland
Dr. Berthold Boedeker Global Biological Development WUP Bayer AG, Germany
Dr. Alex Lazar Director Analytical & Pharmaceutical Sciences ImmunoGen, Inc., US
Dr. Markus Walles Team Lead Metabolism DMPK/IDD Novartis AG, Switzerland
Dr. Cecilia Simonelli Head of Corporate Therapeutic Area: Oncology, Immunology & Anti-Infective Menarini-Ricerch Menarini Group, Italy
Please, complete details below:
Please, complete details below and you will get Agenda via E-mail:
Please, complete details below and you will get 500 € Document Package: